Plasma Prokineticin 1, a prognostic biomarker in colorectal cancer patients with curative resection: a retrospective cohort study

Abstract Background Prokineticin 1 (PROK1) was reported as an angiogenic factor, which is associated with tumor progression, cell invasion, and metastasis in colorectal cancer. Although the association between PROK1 expression in primary cancer lesion and patient prognosis was reported, it is unclea...

Full description

Bibliographic Details
Main Authors: Noriyuki Tagai, Takanori Goi, Michiaki Shimada, Hidetaka Kurebayashi
Format: Article
Language:English
Published: BMC 2021-10-01
Series:World Journal of Surgical Oncology
Subjects:
Online Access:https://doi.org/10.1186/s12957-021-02421-0